Syndax Pharmaceuticals
SNDX
SNDX
163 hedge funds and large institutions have $1.54B invested in Syndax Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 74 increasing their positions, 33 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
163
Holders Change
+3
Holders Change %
+1.88%
% of All Funds
2.61%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.13%
New
31
Increased
74
Reduced
33
Closed
26
Calls
$1.97M
Puts
$3.49M
Net Calls
-$1.52M
Net Calls Change
-$1.72M
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$23.1M |
| 2 |
BI
2
BVF Inc
San Francisco,
California
|
$45.3M |
| 3 |
KCM
3
Kynam Capital Management
Princeton,
New Jersey
|
$67.7M |
| 4 |
EP
4
Eversept Partners
New York
|
$46.7M |
| 5 |
5
BlackRock
New York
|
$104M |
